Filing Flows › Comparisons › NXPL vs ATEX
NextPlat vs Anterix: NXPL and ATEX compared
NextPlat is the larger company: $11.9M of revenue in its latest quarter (Q2 2026) against $2.0M for Anterix (Q1 FY27). Anterix is growing faster (+38% against -10% a year earlier). NextPlat is more profitable, with an operating margin of -1.1% against -12.6%.
Where the money goes: NXPL and ATEX
NextPlat (NXPL) · Q2 2026
NextPlat, Q2 2026: revenue $11.9M (-10% year over year), operating margin -1.1%, net loss $144K, operating cash flow $1.1M. The chart follows the revenue to costs, profit and cash.
Anterix (ATEX) · Q1 FY27
Anterix, Q1 FY27: revenue $2.0M (+38% year over year), operating margin -12.6%, net earnings $240K, operating cash flow $2.0M. The chart follows the revenue to costs, profit and cash.
| NextPlat (NXPL) | Anterix (ATEX) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q1 FY27 |
| Revenue | $11.9M | $2.0M |
| Revenue growth, Y/Y | -10% | +38% |
| Operating margin | -1.1% | -12.6% |
| Net earnings | −$144K | $240K |
| Net margin | -1.2% | 12.3% |
| Operating cash flow | $1.1M | $2.0M |
| Free cash flow | — | $2.0M |
Where the revenue comes from
NextPlat
- Pharmacy Prescription and Other Revenue, Net of PBM Fees: $5.6M (47%)
- E-Commerce Revenue: $4.1M (34%)
- Pharmacy Contract Revenue: $2.2M (19%)
Questions
Which is bigger, NextPlat or Anterix?
NextPlat is the larger company: $11.9M of revenue in its latest quarter (Q2 2026) against $2.0M for Anterix (Q1 FY27).
Is NextPlat or Anterix growing faster?
Anterix is growing faster (+38% against -10% a year earlier).
Which is more profitable, NextPlat or Anterix?
NextPlat is more profitable, with an operating margin of -1.1% against -12.6%.
More: NextPlat earnings · how NextPlat makes money · Anterix earnings · how Anterix makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 14, 2026; 10-Q filed Aug 11, 2026). Fiscal quarters can end on different dates. Not investment advice.